Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

ClinicalTrials.gov ID: NCT01728220

Public ClinicalTrials.gov record NCT01728220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 7:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a placebo-controlled, double-blind, parallel, randomized, two-part, dose-confirming clinical study characterizing the pharmacodynamic effects of pulsed iNO using the combination product, inhaled nitric oxide/INOpulse DS-C vs. placebo in subjects with World Health Organization (WHO) Group 3 pulmonary hypertension (PH) associated with Chronic Obstructive Pulmonary Disease (COPD) on Long Term Oxygen Therapy (LTOT).

Study identification

NCT ID
NCT01728220
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bellerophon Pulse Technologies
Industry
Enrollment
159 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2012 (Type not available)
Primary completion
Jun 2014 (Actual)
Completion
Jul 2014 (Actual)
Last update posted
Feb 27, 2023

2012 – 2014

United States locations

U.S. sites
43
U.S. states
18
U.S. cities
38
Facility City State ZIP Site status
Jasper Summit Research LLC Jasper Alabama 35501 —
Clinical Trial Connection Flagstaff Arizona 86001 —
Pulmonary Associates P.A. Phoenix Arizona 85006 —
Radin Cardiovascular Medical Associates Newport Beach California 92663 —
Western Connecticut Medical Group PC Danbury Connecticut 06810 —
Waterbury Pulmonary Associates Waterbury Connecticut 06708 —
Bay Area Chest Physicians Clearwater Florida 33756 —
Gary J. Richmond, MD, PA Fort Lauderdale Florida 33316 —
East Coast Institute for Research Jacksonville Florida 32204 —
Pulmonary Disease Specialists PA Kissimmee Florida 34741 —
San Marcus Research Clinic Inc. Miami Florida 33015 —
St. Paul Medical Research Center Inc. Miami Florida 33126 —
IMIC, Inc. Miami Florida 33140 —
Elite Clinical Research Miami Florida 33144 —
South Florida Research Phase I-IV Miami Florida 33165 —
Health & Life Research Solutions Inc. Miami Florida 33173 —
Advanced Research Institute, Inc. New Port Richey Florida 34653 —
Central Florida Pulmonary Group, P.A. Orlando Florida 32803 —
Bassette Medical Research Inc. Sebring Florida 33872 —
Research Alliance St. Petersburg Florida 33710 —
Concept Clinical Trials, LLC Tamarac Florida 33319 —
Axcess Medical Research Wellington Florida 33414 —
Florida Premier Research Institute Winter Park Florida 32789 —
River Birch Research Alliance LLC Blue Ridge Georgia 30513 —
Medical Associates of North Georgia Canton Georgia 30114 —
Veritas Clinical Specialties, Ltd Topeka Kansas 66606 —
Graves-Gilbert Clinic Bowling Green Kentucky 42101 —
Kentucky Research Group Louisville Kentucky 40218 —
MedPharmics LLC Metairie Louisiana 70006 —
Physician HealthCare Network, PC Port Huron Michigan 48060 —
Montefiore Medical Center-Weiler Division The Bronx New York 10461 —
American Health Research Charlotte North Carolina 28207 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
Temple Lung Center Pulmonary & Critical Care Medicine Philadelphia Pennsylvania 19140 —
Lowcountry Lung and Critical Care Charleston South Carolina 29406 —
Neem Research Group Inc Columbia South Carolina 29201 —
Gaffney Pharmaceutical Research Gaffney South Carolina 29340 —
Greenville Pharmaceutical Research Greenville South Carolina 29615 —
Clinical Research of Rock Hill Rock Hill South Carolina 29732 —
Spartanburg Medical Research Spartanburg South Carolina 29303 —
Pioneer Research Solutions, Inc. Sugar Land Texas 77479 —
Pulmonary Associates of Richmond Inc Richmond Virginia 23225 —
Zain Research LLC Richland Washington 99352 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01728220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2023 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01728220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →